Therese Gutter
Research Subjects
Therese Gutter has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Al W. de Weerd
Department of Clinical Neurophysiology and Sleep Centre SEIN Zwolle, The Netherlands
2 shared publicationsA.M. Beun
Department of Neurology and Outpatient Epilepsy Departments Zwolle, Groningen and Leeuwarden of 'Meer & Bosch' Epilepsy Centre, Heemstede
1 shared publicationA.W. de Weerd
1 shared publication- Albert P. Aldenkamp
Department of Electrical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands
1 shared publication B. Slot
Department of Neuropsychology, 'Meer & Bosch' Epilepsy Centre, Heemstede
1 shared publicationB. Vledder
Department of Neurology and Outpatient Epilepsy Departments Zwolle, Groningen and Leeuwarden of 'Meer & Bosch' Epilepsy Centre, Heemstede
1 shared publication
Latest Publications
- 1 July 2019
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 69, 298-303
Prevalence of sleep disturbances in people with epilepsy and the impact on quality of life: a survey in secondary care
- 1 July 2019
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 69, 298-303
Prevalence of sleep disturbances in people with epilepsy and the impact on quality of life: a survey in secondary care
- 1 September 2013
- Published by Elsevier in Epilepsy & Behavior
- Vol. 28 (3) , 481-488
Subjective sleep disturbances in children with partial epilepsy and their effects on quality of life
- 1 September 2013
- Published by Elsevier in Epilepsy & Behavior
- Vol. 28 (3) , 481-488
Subjective sleep disturbances in children with partial epilepsy and their effects on quality of life
- 1 October 2012
- Published by Elsevier in Epilepsy & Behavior
- Vol. 25 (2) , 289-294
Effects of daytime secondarily generalized epileptic seizures on sleep during the following night
- 1 October 2012
- Published by Elsevier in Epilepsy & Behavior
- Vol. 25 (2) , 289-294
Effects of daytime secondarily generalized epileptic seizures on sleep during the following night
- 1 January 1995
- Published by S. Karger AG in Neuropsychobiology
- Vol. 32 (1) , 37-44
Effect of Sabeluzole (R 58 735) on Memory Functions in Patients with Epilepsy
Sabeluzole, a new benzothiazol derivative, has shown positive effects on memory function in animals and in normal volunteers. The present study reports the results of sabeluzole, in memory-impaired patients with localization-related (partial) epilepsy. A randomized, double-blind placebo-controlled parallel-group design was used. A total of 38 patients entered a prospective baseline. Five patients dropped out from the study, thus 33 patients were randomly assigned to either a 12-weeks treatment with sabeluzole (n = 14) or placebo (n = 19). The treatment phase was preceded by a titration phase of 4 weeks to obtain serum levels of sabeluzole between 50 and 130 ng/ml. In order to maintain blindness, a sham titration was carried out in the placebo group. The number of 'responders', i.e. patients with a > 1 SD improvement on at least three of the memory tests was 9 out of 14 (64.3%) in the sabeluzole group and 7 out of 19 (36.8%) in the placebo group. This suggests a clinically relevant effect of sabeluzole. The analysis of the memory tests showed a statistically significant improvement with sabeluzole on the verbal long-term memory test. This could represent a specific drug effect and is in line with previous results of normal volunteer studies that also found improvement mainly restricted to the area of verbal long-term memory.
- 1 January 1995
- Published by S. Karger AG in Neuropsychobiology
- Vol. 32 (1) , 37-44
Effect of Sabeluzole (R 58 735) on Memory Functions in Patients with Epilepsy
Sabeluzole, a new benzothiazol derivative, has shown positive effects on memory function in animals and in normal volunteers. The present study reports the results of sabeluzole, in memory-impaired patients with localization-related (partial) epilepsy. A randomized, double-blind placebo-controlled parallel-group design was used. A total of 38 patients entered a prospective baseline. Five patients dropped out from the study, thus 33 patients were randomly assigned to either a 12-weeks treatment with sabeluzole (n = 14) or placebo (n = 19). The treatment phase was preceded by a titration phase of 4 weeks to obtain serum levels of sabeluzole between 50 and 130 ng/ml. In order to maintain blindness, a sham titration was carried out in the placebo group. The number of 'responders', i.e. patients with a > 1 SD improvement on at least three of the memory tests was 9 out of 14 (64.3%) in the sabeluzole group and 7 out of 19 (36.8%) in the placebo group. This suggests a clinically relevant effect of sabeluzole. The analysis of the memory tests showed a statistically significant improvement with sabeluzole on the verbal long-term memory test. This could represent a specific drug effect and is in line with previous results of normal volunteer studies that also found improvement mainly restricted to the area of verbal long-term memory.